DexCom
DXCM • NASDAQ
DexCom is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Jacob Steven Leach, with a market cap of $26.2B.
CEOJacob Steven Leach
Market Cap$26.2B
Medical - Devices
Healthcare
Employees9.6K
Websitedexcom.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for DexCom
Date
Thursday, April 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.47
Revenue Estimate
$1.2B
Earnings History
Past 12 earnings reports for DexCom
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | Q4 2025 | $0.68Est: $0.65 | +4.6% | $1.3BEst: $1.3B | +0.6% |  10-K |
| Oct 30, 2025 | Q3 2025 | $0.61Est: $0.57 | +7.0% | $1.2BEst: $1.2B | +2.5% | 10-Q |
| Jul 30, 2025 | Q2 2025 | $0.48Est: $0.45 | +6.7% | $1.2BEst: $1.1B | +3.0% | 10-Q |
| May 1, 2025 | Q1 2025 | $0.32Est: $0.33 | -3.0% | $1.0BEst: $1.0B | +1.6% | 10-Q |
| Feb 13, 2025 | Q4 2024 | $0.45Est: $0.50 | -10.0% | $1.1BEst: $1.1B | +1.3% | 10-K |
| Oct 24, 2024 | Q3 2024 | $0.45Est: $0.43 | +4.7% | $994.2MEst: $990.7M | +0.4% | 10-Q |
| Jul 25, 2024 | Q2 2024 | $0.43Est: $0.39 | +10.3% | $1.0BEst: $1.0B | -3.5% | 10-Q |
| Apr 25, 2024 | Q1 2024 | $0.32Est: $0.27 | +18.5% | $921.0MEst: $909.2M | +1.3% | 10-Q |
| Feb 8, 2024 | Q4 2023 | $0.50Est: $0.43 | +16.3% | $1.0BEst: $1.0B | +1.4% | 10-K |
| Oct 26, 2023 | Q3 2023 | $0.50Est: $0.34 | +47.1% | $975.0MEst: $939.2M | +3.8% | 10-Q |
| Jul 27, 2023 | Q2 2023 | $0.34Est: $0.23 | +47.8% | $871.3MEst: $841.6M | +3.5% | — |
| Apr 27, 2023 | Q1 2023 | $0.17Est: $0.15 | +13.3% | $741.5MEst: $720.7M | +2.9% | — |